5,919 Shares in Danaher Corporation $DHR Bought by E Fund Management Co. Ltd.

Key Points

• E Fund Management purchased 5,919 shares of Danaher in the second quarter, valued at approximately $1.13 million. Institutional investors collectively own 79.05% of the company.
• Analysts maintain a generally positive outlook, with Danaher holding a “Moderate Buy” consensus rating and an average price target of $228.91, although several firms recently lowered targets or downgraded the stock.
• Danaher reported quarterly earnings of $1.94 per share, beating estimates of $1.85, while revenue rose 5.5% year over year to $6.26 billion.

E Fund Management Co. Ltd. purchased a new stake in Danaher Corporation (NYSE:DHR - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 5,919 shares of the conglomerate's stock, valued at approximately $1,127,000.

Several other hedge funds also recently made changes to their positions in DHR. Main Street Group LTD acquired a new stake in shares of Danaher during the first quarter worth about $25,000. N.E.W. Advisory Services LLC acquired a new stake in shares of Danaher in the 2nd quarter valued at about $25,000. JPL Wealth Management LLC purchased a new position in Danaher during the 3rd quarter worth approximately $25,000. WFA of San Diego LLC acquired a new position in Danaher during the second quarter worth approximately $26,000. Finally, Hilton Head Capital Partners LLC purchased a new stake in Danaher in the fourth quarter valued at approximately $27,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

DHR has been the topic of a number of research reports. Wolfe Research lowered shares of Danaher from an "outperform" rating to a "peer perform" rating in a research report on Monday, June 1st. Stifel Nicolaus reduced their price target on shares of Danaher from $260.00 to $220.00 and set a "buy" rating for the company in a research report on Wednesday, July 22nd. Wall Street Zen cut shares of Danaher from a "buy" rating to a "hold" rating in a research note on Saturday, April 25th. Wells Fargo & Company lowered their price objective on shares of Danaher from $212.00 to $195.00 and set an "equal weight" rating on the stock in a research report on Wednesday, July 22nd. Finally, Citigroup initiated coverage on shares of Danaher in a research note on Tuesday, May 26th. They issued a "buy" rating and a $230.00 price objective on the stock. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $228.91.

Danaher Trading Up 2.2%

Shares of Danaher stock opened at $216.14 on Friday. The firm has a market cap of $151.94 billion, a price-to-earnings ratio of 38.39, a price-to-earnings-growth ratio of 2.63 and a beta of 0.78. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company's 50-day simple moving average is $195.01 and its 200-day simple moving average is $192.43. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion during the quarter, compared to analysts' expectations of $6.12 billion. During the same period last year, the firm earned $0.77 EPS. The company's quarterly revenue was up 5.5% compared to the same quarter last year. As a group, equities research analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source